Medicis Announces Third Quarter 2009 Conference Call and Webcast
02 nov. 2009 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 2, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced it expects to report 2009 third quarter financial results after the market closes on Wednesday, November 4, 2009....
Medicis Receives Notice of Allowance for SOLODYN(R) Patent
13 oct. 2009 16h05 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Oct. 13, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Medicis' United...
Medicis to Present At UBS Global Life Sciences Conference
17 sept. 2009 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 17, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the UBS Global Life Sciences Conference in New York City. A live...
Medicis Declares Cash Dividend
16 sept. 2009 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 16, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.04 per issued and outstanding share of...
Medicis to Present At Morgan Stanley Global Healthcare Conference
10 sept. 2009 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 10, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Morgan Stanley Global Healthcare Unplugged Conference in New...
Medicis to Present At Thomas Weisel Partners Healthcare Conference
08 sept. 2009 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 8, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Thomas Weisel Partners Annual Healthcare Conference in Boston,...
Medicis Reports Second Quarter 2009 Financial Results
05 août 2009 16h05 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Aug. 5, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced record net revenues of approximately $141.2 million for the three months ended June 30, 2009, compared to net...
Medicis Announces Second Quarter 2009 Conference Call and Webcast
31 juil. 2009 08h00 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., July 31, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced it expects to report 2009 second quarter financial results after the market closes on Wednesday, August 5, 2009....
Medicis and Revance Announce Agreement for Development of Next-Gen Neurotoxin
28 juil. 2009 16h34 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz. and NEWARK, Calif., July 28, 2009 (GLOBE NEWSWIRE) -- Medicis Pharmaceutical Corporation (NYSE:MRX) (Medicis) and Revance Therapeutics, Inc. (Revance) today announced that the...
Medicis Announces Approval of New Strengths of SOLODYN(R)
27 juil. 2009 16h05 HE
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., July 27, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration (FDA) has approved additional strengths of SOLODYN(R) (minocycline...